Patents by Inventor Satoko Shibata

Satoko Shibata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anticancer agent containing dendritic cell having RNA virus transferred thereinto
    Patent number: 8889118
    Abstract: The present invention provides anticancer agents comprising dendritic cells introduced with RNA viruses. The present invention also provides methods for producing anticancer agents, which comprise the step of preparing dendritic cells introduced with RNA viruses. The present invention also provides methods for treating cancers using dendritic cells introduced with RNA viruses. The present invention provides effective methods for treating cancers, which use RNA viruses and dendritic cells in combination.
    Type: Grant
    Filed: April 28, 2005
    Date of Patent: November 18, 2014
    Assignee: DNA VEC Research Inc.
    Inventors: Shinji Okano, Yoshikazu Yonemitsu, Katsuo Sueishi, Satoko Shibata, Mamoru Hasegawa, Haruhiko Kondo
  • Anticancer Agent Containing Minus-Strand Rna Virus
    Publication number: 20080031855
    Abstract: Minus-strand RNA viruses were found to have an effective tumor-suppressive effect even when they did not carry a therapeutically effective gene. The present invention provides anticancer agents comprising a minus-strand RNA virus. Furthermore, the present invention provides methods for producing the anticancer agents, which comprise the step of mixing a minus-strand RNA virus with pharmaceutically acceptable carriers. Furthermore, the present invention provides methods for suppressing cancer, which comprise the step of administering a minus-strand RNA virus to cancer tissues.
    Type: Application
    Filed: April 28, 2005
    Publication date: February 7, 2008
    Applicant: DNAVEC RESEARCH INC.
    Inventors: Shinji Okano, Yoshikazu Yonemitsu, Katsuo Sueishi, Satoko Shibata, Mamoru Hasegawa, Haruhiko Kondo
  • Anticancer Agent Containing Dendritic Cell Having Rna Virus Transferred Thereinto
    Publication number: 20080014183
    Abstract: The present invention provides anticancer agents comprising dendritic cells introduced with RNA viruses. The present invention also provides methods for producing anticancer agents, which comprise the step of preparing dendritic cells introduced with RNA viruses. The present invention also provides methods for treating cancers using dendritic cells introduced with RNA viruses.
    Type: Application
    Filed: April 28, 2005
    Publication date: January 17, 2008
    Applicant: DNAVEC RESEARCH INC.
    Inventors: Shinji Okano, Yoshikazu Yonemitsu, Katsuo Sueishi, Satoko Shibata, Mamoru Hasegawa, Haruhiko Kondo
  • Method for Producing Gene Transferred Denritic Cells
    Publication number: 20070269414
    Abstract: The present invention provides a method for introducing a gene into a dendritic cell, which includes the step of contacting a minus-strand RNA virus with a dendritic cell. The present invention also provides a method for producing a gene transferred dendritic cell, which includes the step of contacting a minus-strand RNA virus with a dendritic cell. The present invention also provides gene transferred dendritic cells produced by such methods. Furthermore, the present invention provides a method for activating a dendritic cell, which includes the step of contacting a minus-strand RNA virus with a dendritic cell. The present invention enables efficient gene delivery into dendritic cells. Dendritic cells introduced with antigen gene or cytokine gene are useful as vaccine.
    Type: Application
    Filed: October 29, 2004
    Publication date: November 22, 2007
    Inventors: Shinji Okano, Yoshikazu Yonemitsu, Katsuo Sueishi, Satoko Shibata, Mamoru Hasegawa